A Case of Pathologically Complete Response After Nivolumab Combined with Chemotherapy in a Gastric Cancer Patient with Virchow’s Lymph Node Metastasis
-
Published:2023-07
Issue:
Volume:Volume 16
Page:107-115
-
ISSN:1178-7023
-
Container-title:Clinical and Experimental Gastroenterology
-
language:en
-
Short-container-title:CEG
Author:
Izumo WataruORCID,
Hosoda Kei,
Kuramochi Hidekazu,
Nakajima Go,
Maeda ShinsukeORCID,
Ito ShunichiORCID,
Nagashima Yoji,
Itabashi Michio
Publisher
Informa UK Limited
Reference40 articles.
1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
2. Comparison of the Differences in Survival Rates between the 7th and 8th Editions of the AJCC TNM Staging System for Gastric Adenocarcinoma: a Single-Institution Study of 5,507 Patients in Korea
3. Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
4. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
5. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献